Skip to main content

Table 1 Clinical information of patients with LUSC from the TCGA database

From: Survival-associated N6-adenosine methyltransferase signatures in lung squamous cell carcinoma and clinical verification

Clinical information

Number

Percentage

Total cases

478

100

Survival status

 Alive

290

60.67

 Dead

188

39.33

Over survival time

  < 1 year

142

29.71

 1–5 years

273

57.11

  > 5 years

63

13.18

Age

  < 65

165

34.52

  ≥ 65

313

65.48

Gender

 Male

352

73.64

 Female

126

26.36

Stage

 StageI

233

48.74

 StageII

157

32.85

 StageIII

82

17.15

 StageIV

6

1.26

Tumor

 T1

108

22.59

 T2

281

58.79

 T3

67

14.02

 T4

22

4.60

Node

 N0

308

64.44

 N1

127

26.57

 N2

38

7.95

 N3

5

1.04

Metastasis

 M0

397

83.05

 M1

81

16.95

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us